1. Home
  2. EMBJ vs ABVX Comparison

EMBJ vs ABVX Comparison

Compare EMBJ & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EMBJ

Embraer S.A.

N/A

Current Price

$72.43

Market Cap

12.9B

Sector

Industrials

ML Signal

N/A

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$121.32

Market Cap

10.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBJ
ABVX
Founded
1969
2013
Country
Brazil
France
Employees
N/A
67
Industry
Aerospace
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
10.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EMBJ
ABVX
Price
$72.43
$121.32
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$128.42
AVG Volume (30 Days)
790.9K
707.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.36
$0.22
P/E Ratio
$159.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.73
$4.77
52 Week High
$80.75
$148.83

Technical Indicators

Market Signals
Indicator
EMBJ
ABVX
Relative Strength Index (RSI) 50.16 47.74
Support Level $68.91 $107.99
Resistance Level $74.85 $131.27
Average True Range (ATR) 1.87 4.74
MACD -0.12 -0.19
Stochastic Oscillator 50.39 29.08

Price Performance

Historical Comparison
EMBJ
ABVX

About EMBJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: